news
FDA OKs Opdivo+Yervoy for Mesothelioma
In October 2020, the FDA approved nivolumab plus ipilimumab as the first immunotherapy for mesothelioma, marking the first new treatment in 16 years.
2020 News Archive
3 articles
October 2020
June 2020
legal
$750M Verdict Against J&J in New Jersey Mesothelioma Cases
In June 2020, a New Jersey jury awarded $750 million to four mesothelioma patients who blamed Johnson & Johnson talc products for their cancers.
April 2020
legal
Chris Placitella on 40 Years of Asbestos Trials
Asbestos trial attorney Chris Placitella discusses 40 years of litigation, what corporations knew, and the talc connection in this MesoWatch interview.